Thursday, November 19, 2026 Vol. I · No. 29 · Morning Edition Print size
Election 2026 504 of 506 races called See the results → The GOP Files Receipts on the Republican-run Washington · Sourced · Dated · On the record On Instagram 6.7M plays and counting @thegopfiles →
The Wire
On tape: Trump wants $230 million from the Justice Department, and his own deputy attorney general can approve it Cornyn reportedly shouts at Cruz on Senate floor; Cruz says Democrats are in 'civil war' Trump repeats his 2020 claim that he 'saved' Black colleges; the record says otherwise On tape: Blumenthal confronts Kristi Noem with Donald Trump's own quote on withholding California wildfire aid Pentagon's Colby faults Ukraine's deep strikes in Russia; Germany's Pistorius pushes back On tape: Trump made Senator-elect Abdul El-Sayed the midterms' main character, El-Sayed says Trump says inflation is under 2% for three months; the last official rate was 3.7% 9/11 death claims pass 10,000 as cancer toll among responders and survivors rises On tape: Ro Khanna to JD Vance on the Epstein files: "You're vice president, you're not a pundit." Call for a report. Nike will send custom sneakers to valedictorians nationwide after Sen.-elect Colom's ask On tape: Trump wants $230 million from the Justice Department, and his own deputy attorney general can approve it Cornyn reportedly shouts at Cruz on Senate floor; Cruz says Democrats are in 'civil war' Trump repeats his 2020 claim that he 'saved' Black colleges; the record says otherwise On tape: Blumenthal confronts Kristi Noem with Donald Trump's own quote on withholding California wildfire aid Pentagon's Colby faults Ukraine's deep strikes in Russia; Germany's Pistorius pushes back On tape: Trump made Senator-elect Abdul El-Sayed the midterms' main character, El-Sayed says Trump says inflation is under 2% for three months; the last official rate was 3.7% 9/11 death claims pass 10,000 as cancer toll among responders and survivors rises On tape: Ro Khanna to JD Vance on the Epstein files: "You're vice president, you're not a pundit." Call for a report. Nike will send custom sneakers to valedictorians nationwide after Sen.-elect Colom's ask

Health Care · Report · File No. 261118-825

FDA nominee Overton's confirmation in doubt as Senate vote nears; no pullout confirmed

Heidi Overton, Trump's pick to lead the FDA, was short of Republican votes on the Senate health committee, and the White House had begun looking for a replacement. Our fact desk could not confirm a report that her nomination was dropped.

Every quote in this story (2) was matched word for word against its source. How we work

My clippings
Heidi Overton
Heidi Overton. Photo: The White House, Public domain

The White House was reported on Nov. 17 to be dropping Heidi Overton's nomination to lead the Food and Drug Administration (FDA). The Axios report behind that claim could not be loaded by our fact desk. The two outlets we could read did not report a formal withdrawal, so we are not treating one as confirmed.

What those reports do show is a nomination in serious trouble. CBS News reported on Nov. 17 that Overton was struggling to find enough Republican votes on the Senate Health, Education, Labor and Pensions (HELP) Committee. The committee's vote was scheduled for Wednesday morning, and the nomination could be pulled if she lacked support 1.

The vote count

NBC News reported that Overton needs 11 of the committee's 21 votes. If every Democrat opposes her, she cannot lose a single Republican 2. CBS reported that no Democrats on the panel are expected to back her 1.

Sen. Bill Cassidy, a Louisiana Republican and the committee chairman, has not said how he will vote. On "Face the Nation" on Sunday he said he was unsure whether the committee would advance her 1. Sens. Susan Collins of Maine and Lisa Murkowski of Alaska had not said how they would vote 12.

Bill Cassidy
Do we want a series of short-term administrators who probably will have more influence from the secretary.
Bill Cassidy, chairman of the Senate HELP Committee, R-La.1

The abortion pill question

Mifepristone, a pill used in more than half of U.S. abortions, is central to the fight 1. The FDA is set to finish a safety review of the drug in March, and Overton would oversee it if confirmed 2.

At her September hearing, Overton sidestepped questions on the drug. She said only that it met FDA standards and that she did not want to prejudge the review 2. While at the American First Policy Institute, a conservative group, she called the FDA's decision to allow mail delivery of mifepristone "dangerous to women" 2.

Opposition comes from both sides. Susan B. Anthony Pro-Life America urged the Senate to delay confirmation and wants the FDA to commit to banning mail-order mifepristone. Sen. Josh Hawley, a Missouri Republican, is also among the skeptics 1. Democrats have focused on her abortion record 2.

Susan Collins
I have not taken a position
Susan Collins, U.S. senator, R-Maine2

What happens next

CBS reported that a source said the White House knows it has a problem and has begun looking for a new candidate. The administration has also talked with people who could serve as acting commissioner and avoid Senate confirmation. Sources said Sen. Roger Marshall, a Kansas Republican who lost his reelection bid this month, is seeking the job 1.

Time is short. Democrats take control of the Senate on Jan. 3. A former congressional aide told NBC that if Overton is not confirmed by then, her nomination would likely be returned to the White House. Trump would have to renominate her before a Democratic-controlled Senate, where her chances would be slim 2.

The FDA has had no Senate-confirmed commissioner since Dr. Marty Makary left in the spring. Kyle Diamantas has been acting commissioner since then 12.

That matters because the agency approves drugs and sets the rules for medicines that older Americans rely on. Whoever leads it will also oversee the abortion pill review. This story will be updated when the White House or the committee confirms what happens.

The Record

  1. Overton testifies at her Senate confirmation hearing and sidesteps questions on mifepristone 2.
  2. Cassidy says on Face the Nation that he is unsure whether the committee will advance Overton 1.
  3. CBS reports Overton is struggling for votes and the White House has begun looking for a new candidate 1.
Republish this story on your site or in your newsletter

Any site, blog or newsletter may run this story free of charge. Keep the credit line and its link to the original, do not sell it, and edit only for length or house style (the full terms). Photos carry their own licenses, noted under each photo on this page, so use the text alone unless a credit says otherwise.

Paste it into your editor's HTML view. The one-pixel image at the end tells our newsroom the story ran; it stores no reader data.

Sources

  1. CBS News, “Trump FDA nominee Heidi Overton struggling to win enough GOP support to be confirmed” (2026-11-17). cbsnews.com/news/trump-fda-nominee-heidi-overton-confirmatio
  2. NBC News, “Trump's FDA pick Dr. Heidi Overton faces Republican doubts as confirmation nears” (2026-11-12). nbcnews.com/health/health-news/trump-fda-overton-confirmatio

Found an error? Tell the newsroom. Corrections are noted at the top of the story.

More from the files

Rights

Abortion pill access hangs over Senate panel's Wednesday vote on Trump's FDA pick

A Senate committee votes Nov. 18 on Dr. Heidi Overton, Trump's pick to lead the Food and Drug Administration. The country's best-known anti-abortion group wants senators to hold her up until the administration ends mail-order access to the abortion pill mifepristone. Republicans can lose only one vote.

Delivered free to your door*

The Morning Edition

One short email at 7 a.m. Eastern: the day's top files, one clip worth your time, and the race to watch. Plain English, large type, no clutter.

*Your inbox. Free. Unsubscribe with one click, any time.